Chargement en cours...
Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model
A large number of patients with advanced lymphoma become refractory or relapse after initial treatment due to the persistence of minimal residual disease. Ideal immunotherapy strategy for eradicating the minimal residual disease of lymphoma and preventing the tendency to relapse need to be developed...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4128858/ https://ncbi.nlm.nih.gov/pubmed/24915165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.29453 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|